US 7939468
Methods of identifying compounds that target tRNA splicing endonuclease and uses of said compounds as anti-proliferative agents
granted A61PA61P35/00A61P43/00
Quick answer
US patent 7939468 (Methods of identifying compounds that target tRNA splicing endonuclease and uses of said compounds as anti-proliferative agents) held by PTC THERAPEUTICS, INC. expires Mon May 05 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PTC THERAPEUTICS, INC.
- Grant date
- Tue May 10 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 05 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61P, A61P35/00, A61P43/00